S epsis is the most common cause of ICU admissions and is associated with significant morbidity and mortality (1, 2) . Acute kidney injury (AKI) is a frequent complication in critically ill patients and occurs in nearly 45% of septic patients and 60% of those with septic shock (3) (4) (5) . The combination of sepsis and AKI may synergistically increase mortality rates to up to 50% (5) (6) (7) . Most patients with sepsis have preexisting comorbidities, including chronic kidney disease (CKD) (1) . When compared with those without CKD, those with CKD have a higher incidence and severity of sepsis, as well as increased mortality from sepsis (8) (9) (10) . CKD is now recognized as a relevant poor prognostic factor in patients with sepsis (11, 12) .
Despite the known benefits of fluid therapy in sepsis (13) (14) (15) , the recognition of potential deleterious effects of excessive fluid administration is alarming. Humphrey et al (16) demonstrated a significant decrease in mortality with a fluidconservative resuscitation strategy in a small sample with acute respiratory distress syndrome. More recently, Wiedemann et al (17) showed that a fluid-conservative approach shortened the duration of mechanical ventilation in patients with acute lung injury. Subsequent studies have proposed "fluid accumulation" or "positive fluid balance" as a marker of adverse outcomes in patients with septic shock (2, 18, 19) . Importantly, fluid overload (defined as fluid accumulation > 10% above baseline weight) and mean daily fluid balance were independently associated with mortality in critically ill patients with AKI (20, 21) .
Previous studies have not investigated the impact of cumulative fluid balance (CFB) on adverse outcomes based on incident AKI and/or prevalent CKD stratification. The purpose of the present study was to determine whether CFB was independently associated with hospital mortality in critically ill septic patients with or without incident AKI and prevalent CKD, and whether a differential effect of AKI or CKD on this association could be identified. We also investigated whether the addition of CFB to the admission Sequential Organ Failure Assessment (SOFA) score would improve the prognostic accuracy for hospital mortality.
MATERIALS AND METHODS

Study Design and Participants
We conducted a single-center, retrospective cohort study utilizing a database of patients with severe sepsis or septic shock admitted to the ICU in an urban, tertiary care hospital. Study participants were identified using administrative-linked electronic databases for ICU admissions from May 2007 to April 2012. Severe sepsis or septic shock was defined by Angus et al (1) criteria, using International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes (22) for both a bacterial or fungal infection and a diagnosis of acute organ dysfunction excluding gastrointestinal failure. We included adult patients admitted from the emergency department (ED) to the ICU with a diagnosis of severe sepsis or septic shock who had at least one serum creatinine (SCr) measured and documented in the electronic medical records (EMRs) at two different time points: within 3 months prior to and within the first 72 hours of admission. Patients with absent or incomplete recorded daily fluid balance within the first 72 hours of ICU stay and those with estimated glomerular filtration rate (eGFR) of less than 15 mL/min/1.73 m 2 or receiving chronic dialysis were excluded. The protocol was approved by the institutional review board (7044).
Study Variables
Baseline SCr was defined as the most recent SCr within the 3-month period before ICU admission, which was used to calculate the baseline eGFR using the four-variable Modification of Diet in Renal Disease (MDRD) study equation (23) . Patients were categorized as having AKI if the baseline SCr increased by 0.3 mg/dL or more or by 150% or more or required acute dialysis as defined by Kidney Disease: Improving Global Outcomes SCrbased criteria (24) . The highest SCr within 72 hours of admission was used to determine the occurrence of AKI. Preexisting CKD was defined as baseline eGFR of 15-59 mL/min/1.73 m 2 in the absence of chronic dialysis or end-stage renal disease.
CFB was calculated as follows: total fluid input minus total fluid output within the first 72 hours of ICU stay. Subjectspecific variables were obtained from EMR. Acute Physiology and Chronic Health Evaluation II (APACHE II) (25) and SOFA (26) scores were calculated integrating clinical and laboratory data from the first day of ICU admission. Oliguria was defined as urine output less than 500 mL within 24 hours. Prevalent comorbidity was identified using ICD-9-CM codes, except for anemia that was defined as admission hematocrit less than 39% for men and less than 36% for women. Data pertaining to drug exposure, RBC transfusion, mechanical ventilation, and acute dialysis were based on hospital billing codes for the indexed admission. All collected data were validated through comprehensive individual review of 10% of EMR by data management personnel blinded to the study.
Study Outcome
The observation period was from admission to the ICU until the time of hospital death or discharge. The primary outcome measure was all-cause hospital mortality, adjudicated based on EMR review by data management personnel blinded to the study. AKI) and preexisting CKD (prevalent CKD) as follows: AKI+/ CKD+, AKI-/CKD+, AKI+/CKD-, and AKI-/CKD-. Categorical data were reported as percentages and continuous data as means ± sd or median [25th-75th percentile]. Comparisons between groups for categorical variables were made using the Fisher exact test. For continuous variables, analysis of variance was used for Gaussian and Wilcoxon rank-sum test for non-Gaussian distributed data.
Multivariable logistic regression models were constructed for hospital mortality as the dependent variable and to evaluate CFB as an independent variable. The two-way interaction between incident AKI and prevalent CKD (AKI × CKD) on CFB and on hospital mortality was first evaluated in the entire cohort to validate subgroup stratification if significant (p < 0.1). CFB was modeled as a continuous variable (per 1-L increase) and categorical variable (≥ vs < cut-off value). Optimal predicted probability cut-offs were determined by Youden's index from receiver-operating characteristic (ROC) analysis. Candidate variables for the multivariable models included demographic data (age, gender, and race); comorbidities (diabetes, hypertension, heart failure, and anemia); indicators of critical illness (SOFA and APACHE II scores, oliguria, mechanical ventilation, RBC transfusion, and length of hospital stay [LOS]); and drug exposure (vasoactive drug and diuretic). LOS was dichotomized as greater than or equal to vs less than median value of 12 days. Inclusion into the final model was based upon significance of univariable results and clinical relevance. Only one of two variables was included in the event of collinearity between variables.
To test the model performance of CFB plus admission SOFA score versus SOFA alone for the prediction of hospital mortality, ROC-areas under the curve were compared and continuous net reclassification index (NRI) and absolute integrated discrimination improvement (IDI) were calculated (27) . NRI quantifies the hospital mortality events correctly reclassified with the addition of CFB to the model that included SOFA alone. IDI measures the increment in the predicted probabilities for the hospital mortality subset and the decrement for the subset without hospital mortality. The 95% CI reported for the logistic regression odds ratios (ORs) were based on Wald estimation. Two-sided p values of less than 0.05 indicated statistical significance. Spreadsheet software and SAS 9.4 (SAS Institute, Cary, NC) were used in data acquisition and analysis. Multiple Imputation Method for Missing Baseline SCr Values. A total of 3,070 patients had to be excluded from the primary analysis because of absence of baseline SCr within 3 months prior to ICU admission. As a part of a sensitivity analysis, these missing SCr values were imputed using a linear regression model derived from subject-specific characteristics of the primary study cohort (2,632 patients). Log-transformed SCr was the dependent variable and independent predictors included age, gender, race, diabetes, hypertension, APACHE II score, and their interactions. The association between CFB and hospital mortality was further evaluated in this secondary cohort of 5,688 patients (2,632 with known baseline SCr + 3,056 with imputed baseline SCr, after exclusion of 14 patients with imputed baseline eGFR < 15 mL/min/1.73 m 2 ) (28).
Propensity-Regression Analysis. The primary cohort logistic regression model of CFB (independent variable) and hospital mortality (dependent variable) included a continuous propensity score as a covariate for statistical adjustment. This propensity score was generated from all available study covariates that influenced the occurrence of AKI and/or CKD.
Standardized Mortality Ratio Determination to Examine the Relationship Between CFB and Hospital Mortality.
Standardized mortality ratio (SMR) for each AKI/CKD subgroup by CFB quintiles was calculated as follows: SMR = observed/ predicted mortality; where predicted mortality was determined by the multivariable logistic regression estimate for each AKI/CKD subgroup.
RESULTS
Clinical Characteristics
Of 6,490 patients admitted from the ED to the ICU with the diagnosis of severe sepsis or septic shock, 3,858 were excluded due to the following reasons: no recorded measures of baseline SCr within 3 months before admission; incomplete CFB data at 72 hours; or receiving chronic dialysis (Fig. 1) . The primary study cohort included 2,632 patients: 1,211 (46%) with preexisting CKD defined as an eGFR of 15-59 mL/min/1.73 m 2 and 1,421 (54%) without CKD (eGFR ≥ 60 mL/min/1.73 m 2 ). AKI occurred in 1,525 patients (57.9%), 679 with pre-existing CKD (44.5%) and 846 without CKD (55.5%) ( Fig. 1 ). A total of 238 patients (9.0%) required acute dialysis for AKI.
Clinical characteristics of the cohort are reported in Table 1 . Patients who suffered from AKI, independently of CKD status, had a higher frequency of pressor or inotrope requirement, higher APACHE II and SOFA scores, and more frequent use of mechanical ventilation ( Table 1 ). The median LOS (25th-75th percentile) was 12 days (7-21 d) in the entire cohort. In the CKD group, LOS was not different based on the presence of AKI, whereas in the non-CKD group, those with AKI had a LOS of 12 days (7-20 d) when compared with those without AKI, 13 (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) ; p =0.01) ( Table 1) . Importantly, this difference was influenced by the observation that AKI patients who died had shorter LOS than their non-AKI counterparts: 9 days (4-19 d) versus 14 days (7-25 d), p = 0.007 (data not shown).
Study Outcomes
A total of 603 patients (22.9%) died during the observation period, median LOS of 10 days (4-20 d). A higher proportion of patients with AKI (28.1%) versus without AKI (15.8%) died (p < 0.001). There was significant interaction between AKI and CKD (AKI × CKD) on hospital mortality (p =0. with AKI (25.5%) versus 91 without AKI (17.1%) died in the CKD group (p < 0.001) and 255 with AKI (30.1%) versus 84 without AKI (14.6%) died in the non-CKD group (p < 0.001).
CFB (mean ± sd) at 72 hours was higher in those who died: 7.67 ± 7.94 versus 2.95 ± 6.05 L in survivors (p < 0.001). CFB was also higher in those with AKI requiring dialysis (9.16 ± 8.91 L) than in those with AKI not requiring dialysis (4.61 ± 7.24 L) or in those who did not suffer from AKI (2.80 ± 5.60 L; p for trend < 0.001). CFB was independently associated with hospital mortality in the entire cohort (adjusted OR per 1-L increase [95% CI], 1.06 [1.04-1.08]; p < 0.001). The occurrence of AKI was an independent predictor of hospital mortality (adjusted OR, 1.28 [1.01-1.62]; p = 0.04) but preexisting CKD was not (p = 0.22).
There was a significant interaction between AKI and CKD (AKI × CKD) on CFB (p = 0.005) (Supplemental Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/B857; legend, Supplemental Digital Content 5, http://links.lww.com/CCM/ B861). After subgroup stratification by incident AKI and prevalent CKD, univariable analyses revealed a significant association between CFB and hospital mortality in all subgroups ( Fig. 2A) . After multivariable adjustment, every 1-L increase of CFB at 72 hours was independently associated with hospital mortality, with adjusted ORs (95% CI) of 1.06 (1.03-1.09; p < 0.001) for AKI+/ CKD+; 1.09 (1.05-1.13; p < 0.001) for AKI-/CKD+; 1.05 (1.03-1.08; p < 0.001) for AKI+/CKD-; and 1.07 (1.02-1.11; p = 0.002) for AKI-/CKD-( Fig. 2A and Table 2 ). A similar association with hospital mortality was found when CFB was adjusted by ICU admission body weight (FO per 1% increase). The adjusted ORs (95% CI) were as follows: 1.04 (1.01-1.06; p = 0.005) for AKI+/ CKD+; 1.06 (1.03-1.10; p < 0.001) for AKI-/CKD+; 1.04 (1.02-1.06; p < 0.001) for AKI+/CKD-; 1.05 (1.02-1.09; p = 0.003) for AKI-/CKD- (Fig. 2B) .
CFB Cut-Offs
For each of the four AKI/CKD subgroups, different CFB cutoffs with the best prognostic accuracy for hospital mortality were identified: 5.9 L for AKI+/ CKD+; 3.8 L for AKI-/CKD+; 4.3 L for AKI+/CKD-; and 1.5 L for AKI-/CKD-. The CFB cut-off was lowest if both AKI and CKD were absent (Supplemental Table 1 
Utility of CFB and SOFA Score for the Prediction of Hospital Mortality
CFB at 72 hours was combined with the admission SOFA score in ROC plots for the prediction of hospital mortality in each of the four AKI/CKD subgroups (Fig. 3) . In all subgroups, the model (SOFA + CFB) significantly improved the predictive value for hospital mortality when compared with SOFA alone. This observation was more pronounced in those patients who suffered from AKI regardless of whether CKD was present or absent. The model (SOFA + CFB) significantly improved the risk reclassification of hospital mortality over admission SOFA score alone, as evident by NRI and IDI metrics ( Table 3) .
Sensitivity Analyses
After multiple imputation of missing baseline SCr values, a secondary cohort of 5,688 patients was generated (2,632 with known baseline SCr + 3,056 with imputed baseline SCr). In this secondary cohort, results were essentially the same: CFB was also independently associated with hospital mortality in all patients, adjusted OR per 1-L increase (95% CI) 1.07 (1.06-1.08; p < 0.001). After subgroup stratification by incident AKI and prevalent CKD, CFB at 72 hours was also independently associated with hospital mortality, adjusted ORs (95% CI) of 1.07 (1.05-1.09; p < 0.001) for AKI+/CKD+; 1.07 (1.04-1.09; p < 0.001) for AKI-/CKD+; 1.05 (1.04-1.07; p < 0.001) for AKI+/CKD-; and 1.07 (1.03-1.10; p < 0.001) for AKI-/ CKD- (Supplemental Fig. 3A Fig. 3B , The propensity-regression adjusted OR for hospital mortality in the primary cohort was 1.09 (95% CI, 1.07-1.11; p < 0.001) for every 1-L increase in CFB at 72 hours. In addition, there was a stepwise increase in SMR across CFB quintiles, evident in the entire cohort and in each AKI/CKD subgroup (Fig. 4) .
DISCUSSION
The principle new finding in our study is that the association of higher CFB with hospital mortality is evident in all critically ill septic patients, regardless of the occurrence of AKI and/or preexisting CKD. However, we found a significant interaction between AKI/ CKD categories and CFB such that for the first time, to our knowledge, we characterized different CFB cut-offs associated with hospital mortality based on whether AKI and/or CKD were present. Finally, we showed that combining CFB at 72 hours and admission SOFA score improves the predictive value of the universally accepted SOFA score for hospital mortality.
Fluid therapy in septic shock consists of initial fluid resuscitation followed by conservative fluid management and regulation (29) (30) (31) (32) . The inflammatory cascade of sepsis is thought to disrupt the endothelial surface, alter the microvascular system, and cause capillary leakage (33) (34) (35) . Fluid therapy may enhance filling pressures and improve microcirculation in early sepsis but not in late sepsis (15, 36) . In this context, detrimental consequences of fluid accumulation in critically ill patients, including mortality, have been previously reported in acute lung injury (17, 37) , in sepsis (2, 38) , and in patients with AKI with or without requirement for dialysis (20, 21, (39) (40) (41) .
An observational study of 198 ICUs in 24 European countries revealed that CFB within the first 72 hours of sepsis onset was directly associated with higher mortality, with an OR per 1-L increase of 1.1 (1.0-1.1; p = 0.001) (2) . A secondary analysis of this study later reported that CFB was associated with increased mortality specifically in the subgroup of patients with AKI (29) . One limitation of this study was that AKI was defined as a SCr of greater than 3.5 mg/dL (310 μmol/L) or urine output of less than 500 mL/d, and baseline SCr was not taken into consideration for AKI definition. Our investigation extends these findings by using a more contemporary and accepted AKI definition taking the baseline SCr into account. Later, Bouchard et al (20) reported that fluid overload defined as greater than 10% increase in body weight was associated with 60-day mortality in critically ill patients with AKI, with or without requirement for dialysis. Although this analysis did consider the baseline SCr in the definition of AKI, only patients for whom a nephrology consultation for AKI was obtained were included, which could have led to selection bias. In addition, a non-AKI control group was not included for comparison, and the influence of preexisting CKD was not examined. Furthermore, fluid overload was defined arbitrarily as the accumulation of fluid from 3 days prior to nephrology consultation until hospital discharge, which may not represent a uniform CFB estimate in patients who develop AKI later in the course of ICU stay. In contrast, we used a widely accepted definition for CFB as net fluid accumulated over the first 72 hours of ICU stay. This strategy has been previously tested (2) and provides clinically useful information to more uniformly risk-stratify critically ill septic patients using CFB as an additional clinical parameter.
More recently, Teixeira et al (41) confirmed the association of higher fluid balance with mortality in ICU patients with AKI and demonstrated higher CFB in nonsurvivors than in survivors in the first 7 days of ICU stay. However, this study included only 132 participants with AKI, and the adjudication of AKI occurrence for the primary analysis was based on SCr of greater than or equal to 3.5 mg/dL (310 μmol/L) or urine output less than 500 mL/d, without the use of baseline SCr to assess absolute or relative changes in SCr. Furthermore, recent studies have shown that higher fluid overload at the time of acute dialysis initiation for AKI was associated with 90-day mortality (39) and worse renal recovery at 1 year (40) .
Another important finding in our study was that patients without preexisting CKD that did not develop AKI had the lowest CFB and FO cut-offs associated with hospital mortality. A possible explanation for this observation may be that although in patients without kidney disease excess fluid is usually self-regulated and excreted by preserved renal function, this subgroup may be more susceptible to the negative consequences of acute fluid accumulation than those with preexisting CKD. Patients with CKD, particularly those with edema, may have greater interstitial system adaptation to fluid overload than patients with preserved kidney function (42) . The adaptive response and compliance of the interstitial system (43) can tolerate up to 4.5 L of excess total body fluid before edema becomes evident on physical examination (44) . Ebah et al (45) demonstrated in patients with CKD stages 3 to 5 and obvious edema that both interstitial volume and pressure were significantly increased in comparison with healthy volunteers. This observation may illustrate chronic fluid overload adaptation (42) . An additional observation was that FO cutoffs were all lower than the more than 10% FO cut-off associated with mortality previously reported in literature (20, 46, 47) (Supplemental Table 1 , Supplemental Digital Content 2, http://links.lww.com/CCM/B858). The heterogeneity of these different cut-offs for adverse hospital outcomes in the context of critical illness, sepsis, and kidney disease may be prognostically important but needs further investigation for validation. The purpose of our study was to characterize this heterogeneity rather than to determine specific cut-offs that are readily available for implementation in clinical practice.
Our study has important strengths that need to be delineated. First, we utilized universally accepted AKI and CKD definitions, taking into consideration the baseline SCr. Second, we adjusted the analyses for appropriate confounders, including objective and comprehensive critical illness indicators. Third, we demonstrated a significant interaction between AKI/ CKD categories and CFB and therefore justified our subgroup stratification. Fourth, we characterize CFB cut-offs associated with hospital mortality in each AKI/CKD subgroup. Fifth, we performed rigorous sensitivity analyses: 1) CFB adjustment by ICU admission body weight (FO); 2) imputation method of missing values of baseline SCr to overcome the selection bias inherent to the lack of these data in all participants; 3) propensity-regression analysis; and 4) SMR determination to further examine the association between CFB relative to baseline and risk-adjusted hospital mortality. Sixth, the accuracy of CFB data collection was validated by individual EMR review of 10% of data. Finally, unique to our study is the stratification of participants based on kidney disease status (e.g., the occurrence of AKI and preexisting CKD), and the use of CFB both as continuous and categorical independent predictors.
Our study also has important limitations. First, we did not have hourly urine output data for all participants and therefore did not use urine output criteria for AKI adjudication. Nonetheless, we included oliguria (urine output < 500 mL/d) as a potential confounder in the multivariable models. Second, data pertaining to fluid administration prior to ICU admission were not available for inclusion in the study. However, given that the study subjects are from an institution where standardized goal-directed fluid resuscitation is generally practiced, we can assume similar patterns of pre-ICU fluid therapy for most if not all participants. Third, the determination of eGFR by using the MDRD equation may have led to overclassification of CKD status in a small number of patients although this would have affected only less than 10% of the cohort. Fourth, although we adjusted for confounding by rigorous multivariable regression analyses, residual confounding by unmeasured covariates may not have been completely eliminated. Howbeit, different sensitivity analyses, including propensity-regression analysis, confirmed our results.
CONCLUSIONS
Higher CFB at 72 hours of ICU admission was independently associated with hospital mortality in adult patients with severe sepsis or septic shock, regardless of AKI or CKD presence. The combination of CFB at 72 hours and admission SOFA score improved the predictive value of SOFA score for hospital mortality. Stratification of patients by the occurrence of AKI and preexisting CKD identified different CFB cut-offs associated with hospital mortality, with the lowest CFB cut-off in those without incident AKI or prevalent CKD. The characterization of different CFB cut-offs underpins the heterogeneity of fluid regulation in critical illness, sepsis, and kidney disease. These differences should be further investigated in future prospective studies in which measurements of interstitial volume and microcirculatory dynamics, in addition to intravascular volume, can be used for guiding fluid therapy in critically ill patients with or without kidney disease. Net reclassification index evaluates the incremental effect of adding CFB to SOFA score for the prediction of hospital mortality and quantifies the net number of individuals reclassified correctly using the model of SOFA + CFB compared with SOFA alone with upward reclassification considered beneficial. c Absolute integrated discrimination improvement measures the increment in the predicted probabilities for the hospital mortality subset and the decrement for the subset without hospital mortality between the model of SOFA + CFB vs SOFA alone. Figure 4 . Association between cumulative fluid balance relative to baseline and risk-adjusted hospital mortality. Standardized mortality ratio (SMR) for each acute kidney injury (AKI)/chronic kidney disease (CKD) subgroup by cumulative fluid balance expressed as quintiles was calculated as follows: SMR = observed/predicted mortality; where predicted mortality was determined by the multivariable logistic regression estimate for each AKI/CKD subgroup.
